← Insider buys
TRVI

Trevi Therapeutics, Inc. · Healthcare

10% owner Ali Behbahani bought $25.0M of Trevi Therapeutics, Inc.

Bought$25,000,000
$10.00Price
2,500,000Shares
+129%Stake

What TRVI did for a copier

Prices for TRVI after this filing aren't in yet.

Ali Behbahani's record

5 other buys with 3 months of prices since 2018: on average −10.1% against the S&P 500, and 2 of 5 beat it.

We're building an app that can copy buys like this into your own brokerage. Join the waitlist

Traded Thu, May 9. Filed Mon, May 13, 5:11 PM ET, after the close. Not investment advice.